What does Alkermes Plc do?

Jun 22 2025 06:48 PM IST
share
Share Via
Alkermes Plc is a mid-cap biopharmaceutical company focused on researching, developing, and commercializing pharmaceutical products. As of March 2025, it reported net sales of $307 million and a net profit of $22 million.
Overview:
Alkermes Plc is a biopharmaceutical company engaged in researching, developing, and commercializing pharmaceutical products in the Pharmaceuticals & Biotechnology industry, with a market cap in the mid-cap bracket.

Financial Snapshot:
Most recent Net Sales: 307 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: 22 Million (Quarterly Results - Mar 2025)
Market cap: USD 5,020.84 Million (Mid Cap)

Key Metrics:
P/E: 15.00
Dividend Yield: 0.00%
Debt Equity: -0.58
Return on Equity: 23.57%
Price to Book: 3.32

Contact Details:
Address: Connaught HSE, 1 Burlington Road, DUBLIN None: 00000
Tel: 353 1 7728000
Website: http://www.alkermes.com
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News